Abbott gets FDA approval for AI-powered imaging technology
The new imaging software combines OCT with AI to provide physicians with an enhanced view of coronary blood…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
04 Aug 21
The new imaging software combines OCT with AI to provide physicians with an enhanced view of coronary blood…
06 Jul 21
The Exablate Neuro platform leverages Focused Ultrasound technology to ablate targets deep in the brain for therapeutic effect
29 Jun 21
Panbio Covid-19 Antigen Self-Test leverages Abbott lateral flow technology and is intended for use in adults and children…
09 Jun 21
The SARS-CoV-2 antigen self-test nasal enables users to share results and vaccine status on the company’s digital NAVIFY…
19 May 21
The cobas SARS-CoV-2 Test is now authorised for testing samples from people without symptoms or other reasons to…
29 Apr 21
The two biomarkers include high-sensitive cardiac troponin T (cTnT-hs) and N-terminal pro-brain natriuretic peptide test (NT-proBNP)
27 Apr 21
Lucira CHECK IT Covid-19 self-test is said to be the first self-test authorised by Health Canada for individuals…
12 Apr 21
The LUCIRA Covid-19 All-In-One Test Kit is an FDA-authorised, prescription, molecular diagnostic test that delivers results within 30…
09 Apr 21
The acquisition of Mobidiag will strengthen Hologic’s international and diagnostics businesses
08 Apr 21
Elecsys Anti-p53 is a high precision immunoassay that leverages well-established electrochemiluminescence immunoassay (ECLIA) technology